Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source-Reference-Cited by-同舟云学术

Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source

Published:2024-06 Issue:6 Volume:26 Page:
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:

Author:

von Falkenhausen Aenne S¹²^ORCID,Keidel Linus M³,Wischmann Johannes³^ORCID,Höglinger Günter³^ORCID,Massberg Steffen¹²^ORCID,Kääb Stefan¹²^ORCID,Kellert Lars³,Sinner Moritz F¹²^ORCID

Affiliation:

1. Department of Medicine I, University Hospital, LMU Munich , Ziemssenstrasse 15, 80336 Munich , Germany

2. DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA) , Pettenkoferstrasse 8a and 9, 80336 Munich , Germany

3. Department of Neurology, University Hospital, LMU Munich , Marchioninistrasse 15, 81377 Munich , Germany

Funder

German Research Foundation

Munich Clinician Scientist Program

Clinician Scientist PRogram In Vascular MEdicine

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/europace/article-pdf/26/6/euae141/58340924/euae141.pdf

Reference16 articles.

1. Embolic strokes of undetermined source: the case for a new clinical construct;Hart;Lancet Neurol,2014

2. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association;Kleindorfer;Stroke,2021

3. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke;Sondergaard;N Engl J Med,2017

4. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke;Mas;N Engl J Med,2017

5. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke;Saver;N Engl J Med,2017